Tilia Fiduciary Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8
Closed -$4 529
2023
Q2
$4 Hold
8
﹤0.01% 531
2023
Q1
$5 Hold
8
﹤0.01% 514
2022
Q4
$3 Hold
8
﹤0.01% 508
2022
Q3
$0 Hold
8
﹤0.01% 548
2022
Q2
$0 Hold
8
﹤0.01% 564
2022
Q1
$0 Hold
8
﹤0.01% 580
2021
Q4
$0 Buy
+8
New +$12 ﹤0.01% 560

Other funds holding ASXC

Tilia Fiduciary Partners's ASXC Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 8 shares — an estimated $4 sold.

Tilia Fiduciary Partners first reported a position in ASXC in Q4 2021 and held it in 7 quarters. The position peaked at $5 in Q1 2023. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 8 Asensus Surgical, Inc. shares in Q3 2023, an estimated $4.
  • Tilia Fiduciary Partners first reported a position in Asensus Surgical, Inc. in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Asensus Surgical, Inc. position peaked at $5 in Q1 2023.
  • 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.